Enable Botanical Medicine to Flourish Globally

In 2016 the FDA relaxed botanical drug approval guidelines to catch up with global standards, creating a huge opportunity for the worldwide expansion of botanical medicine. The global botanical medicine industry is an open and untapped $300 billion market. PhytaZenica (“fi-duh-zeh-ni-kuh”) is a healthcare tech company that provides digital products and services to accelerate the development and approval of botanical medicine. Our digital platform provides resources to help facilitate botanical clinical trials, approval and commercialization, as well as provide clinical trial design for botanical therapies.

Led by a team of world-class healthcare and Phyta Zenica technology experts, PhytaZenica is driving the expansion of botanical medicine to transform global healthcare. PhytaZenica is:

a best-in-class marketplace

one-stop shop for the botanical industry

Leave a Reply

Your email address will not be published.